Vice President, Research and Development @ Seer Biologics (March 2012 - June 2014)
Vice President Research @ Carolus Therapeutics (May 2008 - March 2012)
Imaging Scientist @ (January 2005 - January 2008)
Senior Scientist @ Tularik/Amgen (January 1998 - January 2005)
Assistant Professor @ (January 1994 - January 1998)
Postdoctoral Fellow @ (January 1990 - January 1994)
Graduate Student @ (January 1983 - January 1990)
Josh Schultz Education
University of Illinois Chicago
PhD (Biological Chemistry)
1983-1990
Bates College
BS (Bio-Chemistry)
1979-1983
Josh Schultz Skills
Attention to Detail
Biochemistry
Bioconjugation
Biomedical Engineering
Biopharmaceuticals
Biotechnology
Cancer
Cardiovascular Disease
Cell Based Assays
Cell Biology
Cell Culture
Clinical Research
Commercialization
Communication
Communication Training
DNA sequencing
Drug Discovery
Experimental Design
Functional Genomics
Imaging
In Vitro
Life Sciences
Lifesciences
Lipoproteins, Lipids and Atherosclerosis
Literature Reviews
Medical Devices
Molecular Biology
Molecular Diagnostics
Nanotechnology
Neuroscience
Nucleic Acid
Oncology
Oral Communication
Pharmaceutical Industry
Pharmaceuticals
Presentation Skills
Presentations
Problem Solving
R&D
Rare Diseases
Research and Development (R&D)
Solution-oriented
Synthetic Chemistry
Timelines
recombinant DNA technology
Josh Schultz Summary
Josh Schultz, based in Albany, NY, US, is currently a Former Scientific Director, Cardiovascular Disease and Rare Metabolic Diseases, Moderna at TBD Therapeutics. Josh Schultz brings experience from previous roles at Moderna Therapeutics, Seer Biologics and Carolus Therapeutics. Josh Schultz holds a 1983 - 1990 PhD in Biological Chemistry @ University of Illinois Chicago. With a robust skill set that includes Attention to Detail, Biochemistry, Bioconjugation, Biomedical Engineering, Biopharmaceuticals and more. Josh Schultz has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Josh Schultz?
Find contact details for 700 million professionals.